
ABCL
9.74 USD
-6.29%
Today
-6.29%
1D
Market is closed
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 11:00 PM
Sat
Closed
Information
Name
AbCellera Biologics Inc Leveraged
Currency
USD
Core Leverage
1:2
Plus Leverage
1:2
Max Leverage
1:10
Overnight Fees Buy (Core Leverage)
-0.0183%
Overnight Fees Sell (Core Leverage)
-0.0112%
Overnight Fees Buy (Plus Leverage)
-0.0183%
Overnight Fees Sell (Plus Leverage)
-0.0112%
Overnight Fees Buy (Max Leverage)
-0.0183%
Overnight Fees Sell (Max Leverage)
-0.0112%
Market Cap
3.75B
Avg Daily Volume
4.70M
52 Week High
15.015 USD
52 Week Low
2.745 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01830% | $(0.183) |
| SELLS | -0.01120% | $(0.112) |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Top News
AbCellera
-6.29%
ABCL: ABCL635 pairs strong hot-flash efficacy with a targeted mid-2027 Phase III path
tradingview.com
4d ago

AbCellera
-6.29%
NVIDIA
-13.65%
SpaceX
-6.91%
InterConEx
+0.21%
Bloom
-14.54%
Nebius.Group
-15.87%
SanDisk.Corp
-89.47%
Roundhill.Memory
-11.74%
OracleCorp
-8.13%
AMD.Inc
-11.78%
BOAmerica
-2.75%
CapitalOne
-1.55%
Lennar
+1.55%
NetflixInc
-2.79%
RestaurantBrands
+0.87%
Microsoft
-2.83%
UberTech
-2.97%
Visa
+0.05%
ShakeShack
-1.22%
LambWeston
-0.17%
Match-Group
+2.12%
NewsCorp
+4.29%
Meta
-4.88%
Unum
+2.78%
Amazon.com
-3.81%
Norfolk
-0.82%
Applied.Digital
-17.51%
Alphabet
-2.91%
TwnSemiCon
-8.85%
LamRes
-9.63%
Nu_Holdings
-4.18%
SK.Hynix
-14.04%
Salesforce
-0.59%
TexasInstr
-7.18%
Chevron
+1.23%
StateStreet
-2.67%
Intel
-6.94%
CoreWeave
-11.23%
Iris.Energy
-17.78%
WorkdayInc
+2.10%
-4.11%
Apollo
-3.31%
Q3 13F roundup: Big bets on SpaceX, AI and major portfolio exits
tradingview.com
4d ago

AbCellera
-6.29%
Nu_Holdings
-4.18%
VTEX_CFD
+4.92%
SoftBank exits Satellogic, trims stakes in Nu Holdings, VTEX, Ethos, AbCellera in Q3
tradingview.com
5d ago

Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.

